RPg Family Wealth Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-232
Closed -$10.7K 93
2022
Q1
$10.7K Hold
232
﹤0.01% 254
2021
Q4
$14.2K Sell
232
-40
-15% -$2.77K 0.01% 249
2021
Q3
$20.3K Buy
272
+52
+24% +$4.36K 0.01% 226
2021
Q2
$20.4K Buy
+220
New +$18.7K 0.01% 224

Other funds holding ARKG

RPg Family Wealth Advisory's ARKG Position: Q2 2022 in Review

RPg Family Wealth Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 232 shares — an estimated $10.7K sold.

RPg Family Wealth Advisory first reported a position in ARKG in Q2 2021 and held it in 4 quarters. The position peaked at $20.4K in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • RPg Family Wealth Advisory reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • RPg Family Wealth Advisory sold 232 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $10.7K.
  • RPg Family Wealth Advisory first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 4 quarters.
  • RPg Family Wealth Advisory's ARK Genomic Revolution ETF position peaked at $20.4K in Q2 2021.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on RPg Family Wealth Advisory's 13F filing for Q2 2022, filed 12 Aug 2022.